Abstract
Regulation of AMP-activated protein kinase (AMPK) signalling is complex and involves contributions from adenine nucleotides, co-/posttranslational modifications, and isoform composition of the AMPK heterotrimer. It is becoming apparent that AMPK activation/inhibition by synthetic drugs involves similar levels of complexity. Major advances in our understanding of these mechanisms have been gained from recombinant expression systems that provide sufficient quantities of highly purified material for structure/function studies. Here, we provide a detailed protocol for transient expression of affinity-tagged AMPK complexes in mammalian cells. We have found this system to be optimal as a source of enzyme possessing regulatory modifications found in vivo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Oakhill JS, Scott JW, Kemp BE (2012) AMPK functions as an adenylate charge-regulated protein kinase. Trends Endocrinol Metab 23:125–132
Jeon S-M (2016) Regulation and function of AMPK in physiology and diseases. Exp Mol Med 48:e245
Ferrer A, Caelles C, Massot N et al (1985) Activation of rat liver cytosolic 3-hydroxy-3-methylglutaryl coenzyme a reductase kinase by adenosine 5′-monophosphate. Biochem Biophys Res Comm 132:497–504
Hawley SA, Davison M, Woods A et al (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271:27879–27887
Neumann D, Woods A, Carling D et al (2003) Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli. Protein Expr Purif 30:230–237
Iseli TJ, Oakhill JS, Bailey MF et al (2008) AMP-activated protein kinase subunit interactions: beta1:gamma1 association requires beta1 Thr-263 and Tyr-267. J Biol Chem 283:4799–4807
Scott JW, van Denderen BJ, Jorgensen SB et al (2008) Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem Biol 15:1220–1230
Oakhill JS, Chen ZP, Scott JW et al (2010) β-subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc Natl Acad Sci U S A 107:19237–19241
Bonthron DT, Handin RI, Kaufman RJ et al (1986) Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature 324:270–273
Scott JW, Galic S, Graham KL et al (2015) Inhibition of AMP-activated protein kinase at the allosteric drug-binding site promotes islet insulin release. Chem Biol 22:705–711
Scott JW, Ling N, Issa SM et al (2014) Small molecule drug A-769662 and AMP synergistically activate naïve AMPK independent of upstream kinase signalling. Chem Biol 21:619–627
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Oakhill, J.S., Scott, J.W., Dite, T.A. (2018). Transient Expression of AMPK Heterotrimer Complexes in Mammalian Cells. In: Neumann, D., Viollet, B. (eds) AMPK. Methods in Molecular Biology, vol 1732. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7598-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7598-3_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7597-6
Online ISBN: 978-1-4939-7598-3
eBook Packages: Springer Protocols